1
|
Schön F, Seidel B, Blum SFU, Fischer K, Kromrey ML, Riediger C, Löck S, Hoffmann RT, Kühn JP. Experience Matters: Impact on Technical Success and Complication Rate in Percutaneous Transhepatic Biliary Drainage. Acad Radiol 2025; 32:1525-1533. [PMID: 39424531 DOI: 10.1016/j.acra.2024.09.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2024] [Revised: 08/27/2024] [Accepted: 09/11/2024] [Indexed: 10/21/2024]
Abstract
RATIONALE AND OBJECTIVES To investigate factors influencing the success and complication rate of percutaneous transhepatic biliary drainage (PTBD). MATERIALS AND METHODS PTBD procedures between 2017 and 2022 were enrolled retrospectively. Success rate, complications, and technical considerations were compared using Mann-Whitney U-, X2-, and Fishers exact tests. The influence of the study center's experience (training-effect) on success and complication rates was assessed by linear regression categorized by year. RESULTS In 398 patients, 499 PTBD procedures (337 men; mean age 66.2 +/- 12.5 years) were carried out, with a success rate of 83.2% (415/499). PTBD in dilated bile ducts was more successful than in non-dilated bile ducts (90.0%; 316/340 vs. 68.6%; 109/159; p < 0.001), with e.g. lower radiation doses (2787.52 +/- 4012.72 cGy*cm2 vs. 4679.25 +/- 4663.55 cGy*cm2; p < 0.001), and shorter total procedure time (33.42 +/- 24.03 min vs. 41.09 +/- 27.21 min; p < 0.001). Complications occurred in 34/499 (6.8%) procedures (major complications n = 25/34) with no significant difference in bile duct width. Right-sided PTBD revealed more complications (9.0%; 30/332 vs. 2.4%; 4/166; p = 0.006) and higher radiation doses (3679.47 +/- 4571.71 cGy*cm2 vs. 2819.01 +/- 3724.92 cGy*cm2; p = 0.001) than left-sided approaches. Linear regression showed a significant continuous increase in the technical success rate of 3.0% per year (2017-2022; 72.5%; 78.5%; 82.2%; 85.0%; 89.0%; 87.5%; p = 0.005), while the overall complication rate remained unaffected (p = 0.364). CONCLUSION Medical centers adopting PTBD procedures can potentially increase their success rate significantly within a short period of time. PTBD is a safe procedure, with left-sided approaches showing lower complication rates and radiation exposure, underscoring their often-underestimated advantages in clinical practice.
Collapse
Affiliation(s)
- Felix Schön
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.).
| | - Bennet Seidel
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| | - Sophia Freya Ulrike Blum
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| | - Kristina Fischer
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| | - Marie-Luise Kromrey
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| | - Carina Riediger
- Department of Visceral, Thoracic and Vascular Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (C.R.)
| | - Steffen Löck
- OncoRay‑National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany (S.L.)
| | - Ralf-Thorsten Hoffmann
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| | - Jens-Peter Kühn
- Institute and Polyclinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany (F.S., B.S., S.F.U.B., K.F., M.L.K., R.T.H., J.P.K.)
| |
Collapse
|
3
|
Bhayana R, Alwahbi O, Ladak AM, Deng Y, Basso Dias A, Elbanna K, Abreu Gomez J, Jajodia A, Jhaveri K, Johnson S, Kajal D, Wang D, Soong C, Kielar A, Krishna S. Leveraging Large Language Models to Generate Clinical Histories for Oncologic Imaging Requisitions. Radiology 2025; 314:e242134. [PMID: 39903072 DOI: 10.1148/radiol.242134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2025]
Abstract
Background Clinical information improves imaging interpretation, but physician-provided histories on requisitions for oncologic imaging often lack key details. Purpose To evaluate large language models (LLMs) for automatically generating clinical histories for oncologic imaging requisitions from clinical notes and compare them with original requisition histories. Materials and Methods In total, 207 patients with CT performed at a cancer center from January to November 2023 and with an electronic health record clinical note coinciding with ordering date were randomly selected. A multidisciplinary team informed selection of 10 parameters important for oncologic imaging history, including primary oncologic diagnosis, treatment history, and acute symptoms. Clinical notes were independently reviewed to establish the reference standard regarding presence of each parameter. After prompt engineering with seven patients, GPT-4 (version 0613; OpenAI) was prompted on April 9, 2024, to automatically generate structured clinical histories for the 200 remaining patients. Using the reference standard, LLM extraction performance was calculated (recall, precision, F1 score). LLM-generated and original requisition histories were compared for completeness (proportion including each parameter), and 10 radiologists performed pairwise comparison for quality, preference, and subjective likelihood of harm. Results For the 200 LLM-generated histories, GPT-4 performed well, extracting oncologic parameters from clinical notes (F1 = 0.983). Compared with original requisition histories, LLM-generated histories more frequently included parameters critical for radiologist interpretation, including primary oncologic diagnosis (99.5% vs 89% [199 and 178 of 200 histories, respectively]; P < .001), acute or worsening symptoms (15% vs 4% [29 and seven of 200]; P < .001), and relevant surgery (61% vs 12% [122 and 23 of 200]; P < .001). Radiologists preferred LLM-generated histories for imaging interpretation (89% vs 5%, 7% equal; P < .001), indicating they would enable more complete interpretation (86% vs 0%, 15% equal; P < .001) and have a lower likelihood of harm (3% vs 55%, 42% neither; P < .001). Conclusion An LLM enabled accurate automated clinical histories for oncologic imaging from clinical notes. Compared with original requisition histories, LLM-generated histories were more complete and were preferred by radiologists for imaging interpretation and perceived safety. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Tavakoli and Kim in this issue.
Collapse
Affiliation(s)
- Rajesh Bhayana
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Omar Alwahbi
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Aly Muhammad Ladak
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Yangqing Deng
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Adriano Basso Dias
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Khaled Elbanna
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Jorge Abreu Gomez
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Ankush Jajodia
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Kartik Jhaveri
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Sarah Johnson
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Dilkash Kajal
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - David Wang
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Christine Soong
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Ania Kielar
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| | - Satheesh Krishna
- From the Joint Department of Medical Imaging, University Medical Imaging Toronto, Princess Margaret Cancer Centre, University of Toronto, Toronto General Hospital, 200 Elizabeth St, Peter Munk Building, 1st Fl, Toronto, ON, Canada M5G 24C (R.B., O.A., A.B.D., K.E., J.A.G., A.J., K.J., S.J., D.K., D.W., A.K., S.K.); Department of Medicine, University of Toronto, Toronto, Canada (A.M.L.); Department of Biostatistics, University Health Network, Toronto, Canada (Y.D.); and Department of General Internal Medicine, Mount Sinai Hospital, Toronto, Canada (C.S.)
| |
Collapse
|